Free Trial
OTCMKTS:NVZMY

Novozymes A/S (NVZMY) Stock Price, News & Analysis

Novozymes A/S logo
$69.33 -0.53 (-0.75%)
As of 11:44 AM Eastern

About Novozymes A/S Stock (OTCMKTS:NVZMY)

Key Stats

Today's Range
$68.29
$69.47
50-Day Range
$66.00
$75.47
52-Week Range
$53.95
$75.99
Volume
119,444 shs
Average Volume
39,137 shs
Market Capitalization
$32.46 billion
P/E Ratio
43.88
Dividend Yield
1.10%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Novozymes A/S Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

NVZMY MarketRank™: 

Novozymes A/S scored higher than 51% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Novozymes A/S are expected to grow by 17.58% in the coming year, from $1.82 to $2.14 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Novozymes A/S is 43.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.46.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Novozymes A/S is 43.88, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 105.02.

  • Price to Earnings Growth Ratio

    Novozymes A/S has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Novozymes A/S has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Novozymes A/S's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Novozymes A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 179.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Novozymes A/S pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Novozymes A/S does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Novozymes A/S is 48.10%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Novozymes A/S will have a dividend payout ratio of 35.51% next year. This indicates that Novozymes A/S will be able to sustain or increase its dividend.

  • Read more about Novozymes A/S's dividend.
  • Percentage of Shares Shorted

    0.00% of the float of Novozymes A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 179.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Novozymes A/S has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Novozymes A/S this week, compared to 1 article on an average week.
Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Stock News Headlines

Novozymes A/S (NSIS-B.CO) - Yahoo Finance
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
NVZMY Novozymes A/S - Seeking Alpha
Novonesis A/S (NVZMY)
Novonesis price target lowered to DKK 490 from DKK 500 at Barclays
Invitation to the Annual General Meeting
See More Headlines

NVZMY Stock Analysis - Frequently Asked Questions

Novozymes A/S's stock was trading at $56.5399 at the beginning of 2025. Since then, NVZMY shares have increased by 22.6% and is now trading at $69.3250.

Novozymes A/S (OTCMKTS:NVZMY) issued its quarterly earnings data on Wednesday, January, 31st. The biotechnology company reported $0.36 EPS for the quarter, missing the consensus estimate of $0.47 by $0.11. The biotechnology company earned $664.46 million during the quarter.

Novozymes A/S subsidiaries include PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and others.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
1/31/2024
Record date for 4/23 Dividend
4/07/2025
Ex-Dividend for 4/23 Dividend
4/07/2025
Dividend Payable
4/23/2025
Today
7/22/2025
Next Earnings (Estimated)
8/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
CHEM - SPECIALTY
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Previous Symbol
OTC:NVZMY
CIK
1131345
Employees
10,582
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
43.88
Forward P/E Ratio
38.09
P/E Growth
1.32
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
1.66
Quick Ratio
1.04

Sales & Book Value

Annual Sales
$4.15 billion
Price / Sales
7.83
Cash Flow
$1.84 per share
Price / Cash Flow
37.61
Book Value
$25.82 per share
Price / Book
2.68

Miscellaneous

Outstanding Shares
468,300,000
Free Float
N/A
Market Cap
$32.46 billion
Optionable
Not Optionable
Beta
0.91

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:NVZMY) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners